{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:05:41Z","timestamp":1787598341867,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871292"],"award-info":[{"award-number":["81871292"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Four \u201cbatches\u201d innovation project of invigorating medical through science and technology of Shanxi province","award":["2023XM002"],"award-info":[{"award-number":["2023XM002"]}]},{"name":"Fundamental Research Program of Shanxi Province","award":["202303021211218"],"award-info":[{"award-number":["202303021211218"]}]},{"name":"Key Research and Development (R&D) Projects of Shanxi Province","award":["201803D31136"],"award-info":[{"award-number":["201803D31136"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03685-7","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:26:29Z","timestamp":1765535189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical significance of inflammation-coagulation-autoantibody triad in systemic sclerosis-associated interstitial lung disease: a retrospective study"],"prefix":"10.1186","volume":"27","author":[{"given":"Ronghong","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"3685_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390:1685\u201399.","journal-title":"Lancet"},{"key":"3685_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","volume":"8","author":"A Perelas","year":"2020","unstructured":"Perelas A, Silver RM, Arrossi A, V,Highland KB. Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med. 2020;8:304\u201320.","journal-title":"Lancet Respir Med"},{"key":"3685_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41584-023-01044-x","volume":"20","author":"V Liakouli","year":"2024","unstructured":"Liakouli V, Ciancio A, Del Galdo F, Giacomelli R, Ciccia F. Systemic sclerosis interstitial lung disease: unmet needs and potential solutions. Nat Rev Rheumatol. 2024;20:21\u201332.","journal-title":"Nat Rev Rheumatol"},{"key":"3685_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12016-021-08889-8","volume":"64","author":"ME Truchetet","year":"2023","unstructured":"Truchetet ME, Brembilla NC, Chizzolini C. Current concepts on the pathogenesis of systemic sclerosis. Clin Rev Allergy Immunol. 2023;64:262\u201383.","journal-title":"Clin Rev Allergy Immunol"},{"key":"3685_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","volume":"35","author":"VD Steen","year":"2005","unstructured":"Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005;35:35\u201342.","journal-title":"Semin Arthritis Rheum"},{"key":"3685_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/art.41153","volume":"72","author":"SI Nihtyanova","year":"2020","unstructured":"Nihtyanova SI, Sari A, Harvey JC, Leslie A, Derrett-Smith EC, Fonseca C, et al. Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis. Arthritis Rheumatol. 2020;72:465\u201376.","journal-title":"Arthritis Rheumatol"},{"key":"3685_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13877","volume":"53","author":"A Zinellu","year":"2023","unstructured":"Zinellu A, Mangoni AA. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio and disease activity in rheumatoid arthritis: a systematic review and meta-analysis. Eur J Clin Invest. 2023;53:e13877.","journal-title":"Eur J Clin Invest"},{"key":"3685_CR8","volume":"15","author":"G \u015eener","year":"2023","unstructured":"\u015eener G, \u0130nan Yuksel E, G\u00f6kdeniz O, Karaman K, Canat HD. The relationship of hematological parameters and C-reactive protein (CRP) with disease presence, severity, and response to systemic therapy in patients with psoriasis. Cureus. 2023;15:e43790.","journal-title":"Cureus"},{"key":"3685_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102782","author":"J Mercader-Salvans","year":"2023","unstructured":"Mercader-Salvans J, Garc\u00eda-Gonz\u00e1lez M, Quevedo-Abeledo JC, Quevedo-Rodr\u00edguez A, Romo-Cordero A, Ojeda-Bruno S, et al. Blood composite scores in patients with systemic lupus erythematosus. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11102782.","journal-title":"Biomedicines"},{"key":"3685_CR10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/acr.24880","volume":"75","author":"N Wareing","year":"2023","unstructured":"Wareing N, Mohan V, Taherian R, Volkmann ER, Lyons MA, Wilhalme H, et al. Blood neutrophil count and neutrophil-to-lymphocyte ratio for prediction of disease progression and mortality in two independent systemic sclerosis cohorts. Arthritis Care Res Hoboken. 2023;75:648\u201356.","journal-title":"Arthritis Care Res Hoboken"},{"key":"3685_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14145100","author":"G Monteleone","year":"2025","unstructured":"Monteleone G, Passantino L, Simonetti J, Iovene B, Varone F, Cameli P, et al. A simple ratio in a complex disease: exploring the neutrophil-to-lymphocyte ratio in idiopathic pulmonary fibrosis. J Clin Med. 2025. https:\/\/doi.org\/10.3390\/jcm14145100.","journal-title":"J Clin Med"},{"issue":"Suppl 1","key":"3685_CR12","first-page":"S367","volume":"153","author":"RC Chambers","year":"2008","unstructured":"Chambers RC. Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for Pharmacological intervention? Br J Pharmacol. 2008;153(Suppl 1):S367\u201378.","journal-title":"Br J Pharmacol"},{"key":"3685_CR13","doi-asserted-by":"crossref","unstructured":"Bogatkevich GS, Huggins TJ, Ismail AA, Atanelishvili I, Silver RM. Anti-fibrotic effects of thrombin Inhibition in systemic sclerosis-associated interstitial lung disease: proof of concept. J Scleroderma Relat Disord. 2025;23971983241311625.","DOI":"10.1177\/23971983241311625"},{"key":"3685_CR14","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747\u201355.","journal-title":"Ann Rheum Dis"},{"key":"3685_CR15","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1136\/annrheumdis-2015-208024","volume":"75","author":"R Dobrota","year":"2016","unstructured":"Dobrota R, Maurer B, Graf N, Jordan S, Mihai C, Kowal-Bielecka O, et al. Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis. Ann Rheum Dis. 2016;75:1743\u20138.","journal-title":"Ann Rheum Dis"},{"key":"3685_CR16","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/acr.23475","volume":"70","author":"JD Pauling","year":"2018","unstructured":"Pauling JD, Domsic RT, Saketkoo LA, Almeida C, Withey J, Jay H, et al. Multinational qualitative research study exploring the patient experience of Raynaud\u2019s phenomenon in systemic sclerosis. Arthritis Care Res (Hoboken). 2018;70:1373\u201384.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3685_CR17","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/S2665-9913(19)30144-4","volume":"2","author":"AM Hoffmann-Vold","year":"2020","unstructured":"Hoffmann-Vold AM, Maher TM, Philpot EE, Ashrafzadeh A, Barake R, Barsotti S, et al. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. Lancet Rheumatol. 2020;2:e71\u201383.","journal-title":"Lancet Rheumatol"},{"key":"3685_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/ard-2024-226430","volume":"84","author":"F Del Galdo","year":"2025","unstructured":"Del Galdo F, Lescoat A, Conaghan PG, Bertoldo E, \u010coli\u0107 J, Santiago T, et al. EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Ann Rheum Dis. 2025;84:29\u201340.","journal-title":"Ann Rheum Dis"},{"key":"3685_CR19","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1136\/ard.62.9.904","volume":"62","author":"G Valentini","year":"2003","unstructured":"Valentini G, D\u2019Angelo S, Della Rossa A, Bencivelli W, Bombardieri S. European scleroderma study group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis. 2003;62:904\u20135.","journal-title":"Ann Rheum Dis"},{"key":"3685_CR20","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1093\/rheumatology\/kead491","volume":"63","author":"K Morrisroe","year":"2024","unstructured":"Morrisroe K, Hansen D, Stevens W, Ross L, Sahhar J, Ngian GS, et al. Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford). 2024;63:1874\u201381.","journal-title":"Rheumatology (Oxford)"},{"key":"3685_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/art.43051","volume":"77","author":"S Hoa","year":"2025","unstructured":"Hoa S, Berger C, Lahmek N, Larch\u00e9 M, Osman M, Choi M, et al. Characterization of incident interstitial lung disease in late systemic sclerosis. Arthritis Rheumatol. 2025;77:450\u20137.","journal-title":"Arthritis Rheumatol"},{"key":"3685_CR22","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.semarthrit.2020.02.015","volume":"50","author":"A Forestier","year":"2020","unstructured":"Forestier A, Le Gouellec N, B\u00e9hal H, Kramer G, Perez T, Sobanski V, et al. Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: description and prognosis factors. Semin Arthritis Rheum. 2020;50:1406\u201313.","journal-title":"Semin Arthritis Rheum"},{"key":"3685_CR23","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1513\/AnnalsATS.201806-362OC","volume":"15","author":"SA Guler","year":"2018","unstructured":"Guler SA, Winstone TA, Murphy D, Hague C, Soon J, Sulaiman N, et al. Does systemic sclerosis-associated interstitial lung disease burn out? Specific phenotypes of disease progression. Ann Am Thorac Soc. 2018;15:1427\u201333.","journal-title":"Ann Am Thorac Soc"},{"key":"3685_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20576","volume":"9","author":"F Nejatifar","year":"2023","unstructured":"Nejatifar F, Mirbolouk N, Masooleh IS, Kazemnejad E, Ghavidel-Parsa B, Ghanbari AM, et al. Association between neutrophil\/lymphocyte ratio and disease severity in scleroderma patients. Heliyon. 2023;9:e20576.","journal-title":"Heliyon"},{"key":"3685_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1395993","volume":"15","author":"A Zinellu","year":"2024","unstructured":"Zinellu A, Mangoni AA. The association between the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio and systemic sclerosis and its complications: a systematic review and meta-analysis. Front Immunol. 2024;15:1395993.","journal-title":"Front Immunol"},{"key":"3685_CR26","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1093\/rheumatology\/keae606","volume":"64","author":"S Keret","year":"2025","unstructured":"Keret S, Kaly L, Schett G, Bergmann C, Feldman E, Zuckerman T, et al. Neutrophil-to-lymphocyte ratio as a biomarker for clinical response after autologous haematopoietic stem cell transplantation in systemic sclerosis. Rheumatology (Oxford). 2025;64:3160\u20135.","journal-title":"Rheumatology (Oxford)"},{"key":"3685_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/biom14091054","author":"J Luo","year":"2024","unstructured":"Luo J, Xie Z, Duan L. The phenotypes and functions of neutrophils in systemic sclerosis. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14091054.","journal-title":"Biomolecules"},{"key":"3685_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70101","volume":"6","author":"L Zeng","year":"2025","unstructured":"Zeng L, Xiang W, Xiao W, Wu Y, Sun L. The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases. MedComm. 2025;6:e70101.","journal-title":"MedComm"},{"key":"3685_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1189\/jlb.3HI1014-493R","volume":"98","author":"AD Gregory","year":"2015","unstructured":"Gregory AD, Kliment CR, Metz HE, Kim KH, Kargl J, Agostini BA, et al. Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis. J Leukoc Biol. 2015;98:143\u201352.","journal-title":"J Leukoc Biol"},{"key":"3685_CR30","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1007\/s10238-023-01222-x","volume":"23","author":"F Marongiu","year":"2023","unstructured":"Marongiu F, Ruberto MF, Marongiu S, Matucci Cerinic. M,Barcellona D. A journey to vasculopathy in systemic sclerosis: focus on haemostasis and thrombosis. Clin Exp Med. 2023;23:4057\u201364.","journal-title":"Clin Exp Med"},{"key":"3685_CR31","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1182\/bloodadvances.2018018283","volume":"2","author":"D Fran\u00e7ois","year":"2018","unstructured":"Fran\u00e7ois D, Arocas V, Venisse L, Aymonnier K, Idir L, Martos R, et al. Hematopoietic protease nexin-1 protects against lung injury by preventing thrombin signaling in mice. Blood Adv. 2018;2:2389\u201399.","journal-title":"Blood Adv"},{"key":"3685_CR32","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.semarthrit.2010.10.002","volume":"41","author":"A Ludwicka-Bradley","year":"2011","unstructured":"Ludwicka-Bradley A, Silver RM, Bogatkevich GS. Coagulation and autoimmunity in scleroderma interstitial lung disease. Semin Arthritis Rheum. 2011;41:212\u201322.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"3685_CR33","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.2353\/ajpath.2008.080512","volume":"173","author":"JS Blackburn","year":"2008","unstructured":"Blackburn JS, Brinckerhoff CE. Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis. Am J Pathol. 2008;173(6):1736\u201346.","journal-title":"Am J Pathol"},{"key":"3685_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.biocel.2018.02.016","volume":"97","author":"M Schuliga","year":"2018","unstructured":"Schuliga M, Grainge C, Westall G, Knight D. The fibrogenic actions of the coagulant and plasminogen activation systems in pulmonary fibrosis. Int J Biochem Cell Biol. 2018;97:108\u201317.","journal-title":"Int J Biochem Cell Biol"},{"key":"3685_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/imr.13390","volume":"328","author":"WM van Oostveen","year":"2024","unstructured":"van Oostveen WM, Huizinga T, W J,Fehres CM. Pathogenic role of anti-nuclear autoantibodies in systemic sclerosis: insights from other rheumatic diseases. Immunol Rev. 2024;328:265\u201382.","journal-title":"Immunol Rev"},{"key":"3685_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/2397198319869564","volume":"5","author":"WM van den Hombergh","year":"2020","unstructured":"van den Hombergh WM, Knaapen-Hans HK, van den Hoogen FH, Carreira P, Distler O, Hesselstrand R, et al. Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosis. Journal of Scleroderma and Related Disorders. 2020;5:57\u201365.","journal-title":"Journal of Scleroderma and Related Disorders"},{"key":"3685_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152667","volume":"72","author":"EM Hoekstra","year":"2025","unstructured":"Hoekstra EM, Liem SIE, Boonstra M, Fehres CM, Schoones JW, Huizinga TWJ, et al. The prognostic power of anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis - a systematic review of the literature. Semin Arthritis Rheum. 2025;72:152667.","journal-title":"Semin Arthritis Rheum"},{"key":"3685_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1568683","volume":"16","author":"L Cano-Garc\u00eda","year":"2025","unstructured":"Cano-Garc\u00eda L, Garc\u00eda-Studer A, Manrique-Arija S, Ortiz-Marquez F, Redondo-Rodr\u00edguez R, Borreg\u00f3n-Garrido P, et al. Identifying inflammatory phenotypes associated with lung involvement in systemic sclerosis: k-means clustering approach. Front Immunol. 2025;16:1568683.","journal-title":"Front Immunol"},{"key":"3685_CR39","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1002\/art.30539","volume":"63","author":"A Yoshizaki","year":"2011","unstructured":"Yoshizaki A, Yanaba K, Ogawa A, Asano Y, Kadono T, Sato S. Immunization with DNA topoisomerase I and freund\u2019s complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling. Arthritis Rheum. 2011;63:3575\u201385.","journal-title":"Arthritis Rheum"},{"key":"3685_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/2397198319870667","volume":"5","author":"JL Sen\u00e9cal","year":"2020","unstructured":"Sen\u00e9cal JL, Hoa S, Yang R, Koenig M. Pathogenic roles of autoantibodies in systemic sclerosis: current understandings in pathogenesis. Journal of Scleroderma and Related Disorders. 2020;5:103\u201329.","journal-title":"Journal of Scleroderma and Related Disorders"},{"key":"3685_CR41","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41584-025-01276-z","volume":"21","author":"N Maugeri","year":"2025","unstructured":"Maugeri N, Manfredi AA. Platelets as drivers of immunothrombosis in rheumatic diseases. Nat Rev Rheumatol. 2025;21:478\u201393.","journal-title":"Nat Rev Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03685-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03685-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03685-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:26:32Z","timestamp":1765535192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-025-03685-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3685"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03685-7","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"225"}}